An Oxford University study also points out that these vaccines provide “high protection” against hospitalization of patients infected with the Indian-associated variant.
Vaccines produced by AstraZeneca and Pfizer/BioNTech are effective against the Delta variant and provide “high protection” against hospitalization of patients infected with the variant associated with India.
The Oxford University Study, published in the scientific journal Cell, investigated the ability of antibodies in the blood of vaccinated individuals, with two doses of these vaccines, to neutralize the highly contagious variant whose prevalence has increased in Portugal and, especially, in Lisbon and Vale do Tejo, where it is already dominant.
“There is no evidence of widespread transmission, suggesting that current vaccination confers protection against the B.1,617 strains,” the study points out, referring to the variants now known as Delta and Kappa.
Source: SÁBADO by www.sabado.pt.
*The article has been translated based on the content of SÁBADO by www.sabado.pt. If there is any problem regarding the content, copyright, please leave a report below the article. We will try to process as quickly as possible to protect the rights of the author. Thank you very much!
*We just want readers to access information more quickly and easily with other multilingual content, instead of information only available in a certain language.
*We always respect the copyright of the content of the author and always include the original link of the source article.If the author disagrees, just leave the report below the article, the article will be edited or deleted at the request of the author. Thanks very much! Best regards!